Ticker
CRDFCompany Name
CARDIFF ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 75.74M | $ 1.19M | 1.56% |
3/31/2025 | $ 84.81M | $ 1.36M | 1.6% |
12/31/2024 | $ 97.19M | $ 1.52M | 1.57% |
9/30/2024 | $ 62.9M | $ 1.69M | 2.68% |
6/30/2024 | $ 66.05M | $ 1.84M | 2.79% |
3/31/2024 | $ 74.04M | $ 2M | 2.7% |
12/31/2023 | $ 81.64M | $ 2.15M | 2.63% |
9/30/2023 | $ 88.45M | $ 2.29M | 2.59% |
6/30/2023 | $ 97.45M | $ 2.44M | 2.5% |
3/31/2023 | $ 106.55M | $ 2.58M | 2.42% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for CARDIFF ONCOLOGY INC is calculated as follows: Debt [ $ 1.4M ] / Assets [ $ 39.45M ]
(=) Debt to Assets [ 3.54% ]
Minimum
Jun 30, 2021
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.33% |
median | 21.07% |
std | 24.52% |